Clinical Trials Logo

Clinical Trial Summary

With the increasing of the elderly population, patients with urinary dysfunction caused by inefficiency of bladder emptying becomes much often than before. However, the current treatments for this kind of bladder dysfunction are limited and unsatisfactory. Low-intensity extracorporeal shockwave therapy (LiESWT) is a very popular emerging treatment in recent years, and abundant of literatures have confirmed that this treatment is safe and effective in myofascial pain and male erectile dysfunction. Recently, many animal experiments have showed that LiESWT could improve urinary dysfunction caused by bladder dysfunction. Taiwan based studies also reported that LiESWT could improve symptoms of overactive bladder. LiESWT is a non-drug, low-invasive and high-safety treatment, which is very suitable for elderly patients. In this study investigator combine the LiESWT and acupuncture to treat the patients with underactive bladder. Investigator hypothesize that LiESWT could improve bladder voiding efficiency.


Clinical Trial Description

This is a randomized controlled trial, the inclusion criteria are the patients more than 20 years old and bladder voiding efficiency less than 70%, this trial will enroll 60 male and 40 female , total 100 patients. The male will be randomly assigned into three groups(Group-1, Group-2, Group-3) by ratio 1:1:1, and the female will be randomly assigned into two groups (Group-1, Group-2) by ratio 1:1. Group-1: LiESWT on acupoint CV-4, and bilateral ST-28 once a week for 8 weeks, Group-2: LiESWT on acupoint CV-4 and bilateral acupoint SP-6 once a week for 8 weeks, Group-3: Treatment with oral tamsulosin 0.2mg per-day for 8 weeks. The primary outcome is the improvement of bladder voiding efficiency. The secondary outcomes are global response assessment scale, the improvement of maximum uroflow rate, post-voiding residual urine amount, total score of international prostate symptom score. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06020963
Study type Interventional
Source Taichung Armed Forces General Hospital
Contact Jing-Dung Shen, MD
Phone +886958878129
Email jdwhydo@gmail.com
Status Recruiting
Phase N/A
Start date August 11, 2023
Completion date December 31, 2024

See also
  Status Clinical Trial Phase
Completed NCT04161183 - Extracoporeal Shock Wave Therapy (ESWT) for the Treatment of Detrusor Underactivity/ Underactive Bladder (DU/UAB) N/A
Completed NCT04543552 - A Comparative Analysis of Portable Bladder Scanner to Determine Age/ Volume Specific Accuracy in 0-6 Years of Children
Completed NCT04336280 - Detrusor Underactivity: Presentation and Urodynamic Characteristics
Completed NCT05359484 - Delta Q Value to Discriminate Detrusor Underactivity From Bladder Outlet Obstruction Phase 2/Phase 3
Completed NCT00441428 - Safety And Efficacy Of Solifenacin In Men With Overactive Bladder (OAB) And Detrusor Underactivity Phase 2
Completed NCT05470751 - GentleCathâ„¢ for Men Intermittent Catheter With FeelCleanâ„¢ Technology
Completed NCT04981080 - DU and BOO in Women With and Without Symptoms of VD
Completed NCT03175029 - Exploratory Study of TAC-302 in Detrusor Underactivity Patients With Overactive Bladder. Phase 2
Active, not recruiting NCT02193451 - Urodynamics for Prostate Surgery Trial; Randomised Evaluation of Assessment Methods N/A